The Value of Combining Wu Ling San Plus and Minus with Repaglinide in the Treatment of Obese Type 2 Diabetes Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.22158/rhs.v8n2p1
Objective: To investigate the clinical value and practical effects of the treatment of obese type 2 diabetes mellitus patients with Wu Ling San plus and minus combined with Repaglinide. Methods: Twenty-two obese type 2 diabetic patients attending the outpatient clinic of Yixing Traditional Chinese Medicine Hospital from September 2020 to March 2022 were randomly selected as the subjects of this study, and all of them were divided into treatment group (n=11, Wu Ling San plus and minus + Repaglinide) and control group (n=11, single Repaglinide) according to the computerized random series grouping method. The clinical data and overall efficacy of the two groups were compared. Results: After treatment, the treatment group had better blood glucose, blood lipids and other basic indicators than the control group (P<0.05); all Chinese medicine symptoms scores and complication rates of the treatment group were lower than those of the control group (P<0.05). Conclusion: The treatment of obese type 2 diabetes mellitus patients with Wu Ling San plus reduction + Repaglinide has significant efficacy and high drug safety, and can stabilize many indicators of blood glucose and blood lipids, reduce the risk of complications and control their body weight, which can be promoted and used in the treatment of related clinical conditions.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.22158/rhs.v8n2p1
- http://www.scholink.org/ojs/index.php/rhs/article/download/15836/6923
- OA Status
- diamond
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4360978418
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4360978418Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.22158/rhs.v8n2p1Digital Object Identifier
- Title
-
The Value of Combining Wu Ling San Plus and Minus with Repaglinide in the Treatment of Obese Type 2 DiabetesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-27Full publication date if available
- Authors
-
Mingxuan Wang, Huijie Yin, Haitao Li, Penghua Fang, Wenxuan WuList of authors in order
- Landing page
-
https://doi.org/10.22158/rhs.v8n2p1Publisher landing page
- PDF URL
-
https://www.scholink.org/ojs/index.php/rhs/article/download/15836/6923Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://www.scholink.org/ojs/index.php/rhs/article/download/15836/6923Direct OA link when available
- Concepts
-
Repaglinide, Medicine, Diabetes mellitus, Internal medicine, Type 2 diabetes, Type 2 Diabetes Mellitus, EndocrinologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4360978418 |
|---|---|
| doi | https://doi.org/10.22158/rhs.v8n2p1 |
| ids.doi | https://doi.org/10.22158/rhs.v8n2p1 |
| ids.openalex | https://openalex.org/W4360978418 |
| fwci | 0.0 |
| type | article |
| title | The Value of Combining Wu Ling San Plus and Minus with Repaglinide in the Treatment of Obese Type 2 Diabetes |
| biblio.issue | 2 |
| biblio.volume | 8 |
| biblio.last_page | p1 |
| biblio.first_page | p1 |
| topics[0].id | https://openalex.org/T10528 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9799000024795532 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Adipokines, Inflammation, and Metabolic Diseases |
| topics[1].id | https://openalex.org/T12582 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9753999710083008 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2736 |
| topics[1].subfield.display_name | Pharmacology |
| topics[1].display_name | Flavonoids in Medical Research |
| topics[2].id | https://openalex.org/T12673 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9702000021934509 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1305 |
| topics[2].subfield.display_name | Biotechnology |
| topics[2].display_name | Microbial Metabolism and Applications |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2781281211 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9783962965011597 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q2195995 |
| concepts[0].display_name | Repaglinide |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.8831346035003662 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C555293320 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5941960215568542 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q12206 |
| concepts[2].display_name | Diabetes mellitus |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5725584626197815 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C2777180221 |
| concepts[4].level | 3 |
| concepts[4].score | 0.55830979347229 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3025883 |
| concepts[4].display_name | Type 2 diabetes |
| concepts[5].id | https://openalex.org/C2910068830 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4523344039916992 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q3025883 |
| concepts[5].display_name | Type 2 Diabetes Mellitus |
| concepts[6].id | https://openalex.org/C134018914 |
| concepts[6].level | 1 |
| concepts[6].score | 0.2319422960281372 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[6].display_name | Endocrinology |
| keywords[0].id | https://openalex.org/keywords/repaglinide |
| keywords[0].score | 0.9783962965011597 |
| keywords[0].display_name | Repaglinide |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.8831346035003662 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/diabetes-mellitus |
| keywords[2].score | 0.5941960215568542 |
| keywords[2].display_name | Diabetes mellitus |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.5725584626197815 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/type-2-diabetes |
| keywords[4].score | 0.55830979347229 |
| keywords[4].display_name | Type 2 diabetes |
| keywords[5].id | https://openalex.org/keywords/type-2-diabetes-mellitus |
| keywords[5].score | 0.4523344039916992 |
| keywords[5].display_name | Type 2 Diabetes Mellitus |
| keywords[6].id | https://openalex.org/keywords/endocrinology |
| keywords[6].score | 0.2319422960281372 |
| keywords[6].display_name | Endocrinology |
| language | en |
| locations[0].id | doi:10.22158/rhs.v8n2p1 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210204693 |
| locations[0].source.issn | 2470-6205, 2470-6213 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2470-6205 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Research in Health Science |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].source.host_organization_lineage | |
| locations[0].license | cc-by |
| locations[0].pdf_url | http://www.scholink.org/ojs/index.php/rhs/article/download/15836/6923 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Research in Health Science |
| locations[0].landing_page_url | https://doi.org/10.22158/rhs.v8n2p1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5101693711 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-1107-4035 |
| authorships[0].author.display_name | Mingxuan Wang |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I881766915 |
| authorships[0].affiliations[0].raw_affiliation_string | College of Pharmacy, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China |
| authorships[0].institutions[0].id | https://openalex.org/I881766915 |
| authorships[0].institutions[0].ror | https://ror.org/01rxvg760 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I881766915 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Nanjing University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Mingxuan Wang |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | College of Pharmacy, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China |
| authorships[1].author.id | https://openalex.org/A5031501861 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Huijie Yin |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I131434179 |
| authorships[1].affiliations[0].raw_affiliation_string | School of Chinese Medicine, School of Integrated Chinese and Western Medicine, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China |
| authorships[1].institutions[0].id | https://openalex.org/I131434179 |
| authorships[1].institutions[0].ror | https://ror.org/04523zj19 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I131434179 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Nanjing University of Chinese Medicine |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Huijie Yin |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | School of Chinese Medicine, School of Integrated Chinese and Western Medicine, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China |
| authorships[2].author.id | https://openalex.org/A5100453293 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-1137-5487 |
| authorships[2].author.display_name | Haitao Li |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I881766915 |
| authorships[2].affiliations[0].raw_affiliation_string | College of Pharmacy, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China |
| authorships[2].institutions[0].id | https://openalex.org/I881766915 |
| authorships[2].institutions[0].ror | https://ror.org/01rxvg760 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I881766915 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Nanjing University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Haitao Li |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | College of Pharmacy, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China |
| authorships[3].author.id | https://openalex.org/A5070021070 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-8915-0616 |
| authorships[3].author.display_name | Penghua Fang |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I881766915 |
| authorships[3].affiliations[0].raw_affiliation_string | The First College of Clinical Medicine, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China |
| authorships[3].institutions[0].id | https://openalex.org/I881766915 |
| authorships[3].institutions[0].ror | https://ror.org/01rxvg760 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I881766915 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Nanjing University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Penghua Fang |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | The First College of Clinical Medicine, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China |
| authorships[4].author.id | https://openalex.org/A5052774438 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-5459-8990 |
| authorships[4].author.display_name | Wenxuan Wu |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I881766915 |
| authorships[4].affiliations[0].raw_affiliation_string | The First College of Clinical Medicine, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China |
| authorships[4].institutions[0].id | https://openalex.org/I881766915 |
| authorships[4].institutions[0].ror | https://ror.org/01rxvg760 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I881766915 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Nanjing University |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Wenxuan Wu |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | The First College of Clinical Medicine, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, China |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://www.scholink.org/ojs/index.php/rhs/article/download/15836/6923 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | The Value of Combining Wu Ling San Plus and Minus with Repaglinide in the Treatment of Obese Type 2 Diabetes |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10528 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9799000024795532 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Adipokines, Inflammation, and Metabolic Diseases |
| related_works | https://openalex.org/W4233849132, https://openalex.org/W2383009242, https://openalex.org/W1563850031, https://openalex.org/W2415759662, https://openalex.org/W2059951325, https://openalex.org/W3036934084, https://openalex.org/W2233866314, https://openalex.org/W4239196869, https://openalex.org/W2136047525, https://openalex.org/W2415560646 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.22158/rhs.v8n2p1 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210204693 |
| best_oa_location.source.issn | 2470-6205, 2470-6213 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2470-6205 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Research in Health Science |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.source.host_organization_lineage | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | http://www.scholink.org/ojs/index.php/rhs/article/download/15836/6923 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Research in Health Science |
| best_oa_location.landing_page_url | https://doi.org/10.22158/rhs.v8n2p1 |
| primary_location.id | doi:10.22158/rhs.v8n2p1 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210204693 |
| primary_location.source.issn | 2470-6205, 2470-6213 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2470-6205 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Research in Health Science |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.source.host_organization_lineage | |
| primary_location.license | cc-by |
| primary_location.pdf_url | http://www.scholink.org/ojs/index.php/rhs/article/download/15836/6923 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Research in Health Science |
| primary_location.landing_page_url | https://doi.org/10.22158/rhs.v8n2p1 |
| publication_date | 2023-03-27 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.+ | 77, 163 |
| abstract_inverted_index.2 | 15, 33, 153 |
| abstract_inverted_index.To | 1 |
| abstract_inverted_index.Wu | 20, 71, 158 |
| abstract_inverted_index.as | 55 |
| abstract_inverted_index.be | 195 |
| abstract_inverted_index.in | 199 |
| abstract_inverted_index.of | 9, 12, 40, 58, 63, 99, 134, 142, 150, 177, 186, 202 |
| abstract_inverted_index.to | 49, 86 |
| abstract_inverted_index.San | 22, 73, 160 |
| abstract_inverted_index.The | 93, 148 |
| abstract_inverted_index.all | 62, 126 |
| abstract_inverted_index.and | 6, 24, 61, 75, 79, 96, 117, 131, 168, 172, 180, 188, 197 |
| abstract_inverted_index.can | 173, 194 |
| abstract_inverted_index.had | 111 |
| abstract_inverted_index.has | 165 |
| abstract_inverted_index.the | 3, 10, 37, 56, 87, 100, 108, 122, 135, 143, 184, 200 |
| abstract_inverted_index.two | 101 |
| abstract_inverted_index.2020 | 48 |
| abstract_inverted_index.2022 | 51 |
| abstract_inverted_index.Ling | 21, 72, 159 |
| abstract_inverted_index.body | 191 |
| abstract_inverted_index.data | 95 |
| abstract_inverted_index.drug | 170 |
| abstract_inverted_index.from | 46 |
| abstract_inverted_index.high | 169 |
| abstract_inverted_index.into | 67 |
| abstract_inverted_index.many | 175 |
| abstract_inverted_index.plus | 23, 74, 161 |
| abstract_inverted_index.risk | 185 |
| abstract_inverted_index.than | 121, 140 |
| abstract_inverted_index.them | 64 |
| abstract_inverted_index.this | 59 |
| abstract_inverted_index.type | 14, 32, 152 |
| abstract_inverted_index.used | 198 |
| abstract_inverted_index.were | 52, 65, 103, 138 |
| abstract_inverted_index.with | 19, 27, 157 |
| abstract_inverted_index.After | 106 |
| abstract_inverted_index.March | 50 |
| abstract_inverted_index.basic | 119 |
| abstract_inverted_index.blood | 113, 115, 178, 181 |
| abstract_inverted_index.group | 69, 81, 110, 124, 137, 145 |
| abstract_inverted_index.lower | 139 |
| abstract_inverted_index.minus | 25, 76 |
| abstract_inverted_index.obese | 13, 31, 151 |
| abstract_inverted_index.other | 118 |
| abstract_inverted_index.rates | 133 |
| abstract_inverted_index.their | 190 |
| abstract_inverted_index.those | 141 |
| abstract_inverted_index.value | 5 |
| abstract_inverted_index.which | 193 |
| abstract_inverted_index.(n=11, | 70, 82 |
| abstract_inverted_index.Yixing | 41 |
| abstract_inverted_index.better | 112 |
| abstract_inverted_index.clinic | 39 |
| abstract_inverted_index.groups | 102 |
| abstract_inverted_index.lipids | 116 |
| abstract_inverted_index.random | 89 |
| abstract_inverted_index.reduce | 183 |
| abstract_inverted_index.scores | 130 |
| abstract_inverted_index.series | 90 |
| abstract_inverted_index.single | 83 |
| abstract_inverted_index.study, | 60 |
| abstract_inverted_index.Chinese | 43, 127 |
| abstract_inverted_index.control | 80, 123, 144, 189 |
| abstract_inverted_index.divided | 66 |
| abstract_inverted_index.effects | 8 |
| abstract_inverted_index.glucose | 179 |
| abstract_inverted_index.lipids, | 182 |
| abstract_inverted_index.method. | 92 |
| abstract_inverted_index.overall | 97 |
| abstract_inverted_index.related | 203 |
| abstract_inverted_index.safety, | 171 |
| abstract_inverted_index.weight, | 192 |
| abstract_inverted_index.Hospital | 45 |
| abstract_inverted_index.Medicine | 44 |
| abstract_inverted_index.Methods: | 29 |
| abstract_inverted_index.Results: | 105 |
| abstract_inverted_index.clinical | 4, 94, 204 |
| abstract_inverted_index.combined | 26 |
| abstract_inverted_index.diabetes | 16, 154 |
| abstract_inverted_index.diabetic | 34 |
| abstract_inverted_index.efficacy | 98, 167 |
| abstract_inverted_index.glucose, | 114 |
| abstract_inverted_index.grouping | 91 |
| abstract_inverted_index.medicine | 128 |
| abstract_inverted_index.mellitus | 17, 155 |
| abstract_inverted_index.patients | 18, 35, 156 |
| abstract_inverted_index.promoted | 196 |
| abstract_inverted_index.randomly | 53 |
| abstract_inverted_index.selected | 54 |
| abstract_inverted_index.subjects | 57 |
| abstract_inverted_index.symptoms | 129 |
| abstract_inverted_index.September | 47 |
| abstract_inverted_index.according | 85 |
| abstract_inverted_index.attending | 36 |
| abstract_inverted_index.compared. | 104 |
| abstract_inverted_index.practical | 7 |
| abstract_inverted_index.reduction | 162 |
| abstract_inverted_index.stabilize | 174 |
| abstract_inverted_index.treatment | 11, 68, 109, 136, 149, 201 |
| abstract_inverted_index.Objective: | 0 |
| abstract_inverted_index.Twenty-two | 30 |
| abstract_inverted_index.indicators | 120, 176 |
| abstract_inverted_index.outpatient | 38 |
| abstract_inverted_index.treatment, | 107 |
| abstract_inverted_index.Conclusion: | 147 |
| abstract_inverted_index.Repaglinide | 164 |
| abstract_inverted_index.Traditional | 42 |
| abstract_inverted_index.conditions. | 205 |
| abstract_inverted_index.investigate | 2 |
| abstract_inverted_index.significant | 166 |
| abstract_inverted_index.(P<0.05). | 146 |
| abstract_inverted_index.(P<0.05); | 125 |
| abstract_inverted_index.Repaglinide) | 78, 84 |
| abstract_inverted_index.Repaglinide. | 28 |
| abstract_inverted_index.complication | 132 |
| abstract_inverted_index.computerized | 88 |
| abstract_inverted_index.complications | 187 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8500000238418579 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.05738251 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |